0001209191-18-003008.txt : 20180109 0001209191-18-003008.hdr.sgml : 20180109 20180109180015 ACCESSION NUMBER: 0001209191-18-003008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180105 FILED AS OF DATE: 20180109 DATE AS OF CHANGE: 20180109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ketchum Steven B CENTRAL INDEX KEY: 0001289884 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 18519938 MAIL ADDRESS: STREET 1: 2483 EAST BAYSHORE ROAD STREET 2: SUITE 100 CITY: PALO ALTO STATE: CA ZIP: 94303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-05 0 0000897448 AMARIN CORP PLC\UK AMRN 0001289884 Ketchum Steven B C/O AMARIN PHARMA, INC. 1430 ROUTE 206 BEDMINSTER NJ 07921 0 1 0 0 Chief Scientific Officer Ordinary Shares 2018-01-05 4 M 0 64683 2.04 A 206480 D Ordinary Shares 2018-01-05 4 S 0 64683 4.4004 D 141797 D Stock Option (right to buy) 2.04 2018-01-05 4 M 0 64683 0.00 D 2024-01-08 Ordinary Shares 64683 137817 D The exercise and sale transaction reported in the Form 4 is made pursuant to a Rule 10b5-1 plan. The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $4.41, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price. Please see the section titled "Remarks" below for additional information. On January 8, 2014, the Reporting Person was granted an option to purchase 202,500 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option are fully vested and exercisable as of the date of this Form 4. As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 2,757,127 Ordinary Shares of the Issuer in the form of Ordinary Shares, and stock options and Restricted Stock Units granted under the Amarin Corporation plc 2002 Stock Option Plan and the Amarin Corporation plc 2011 Stock Incentive Plan. /s/ Steven B. Ketchum 2018-01-09